Simulations Plus (NASDAQ:SLP) will release its quarterly earnings report on Wednesday, 2024-10-23. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Simulations Plus ...
Simulations Plus (NASDAQ:SLP) is gearing up to announce its quarterly earnings on Monday, 2025-07-14. Here's a quick overview of what investors should know before the release. Analysts are estimating ...
Simulations Plus is a software company that develops tools for modeling and simulation in the pharmaceutical, biotechnology, and chemical industries. In June 2024, Simulations Plus acquired ...
Simulations Plus appears to be a unique Buy candidate, driven by an ultra-low valuation and the potential for AI-inspired growth in drug discovery modeling. The FDA Modernization Act 2.0 and industry ...
Simulations Plus faces soft revenue growth in the short term, due largely to macro conditions. The negatives appear to have been priced in, though, after a period of significant share price declines.
Simulations Plus is a software company that develops tools for modeling and simulation in the pharmaceutical, biotechnology, and chemical industries. In June 2024, Simulations Plus acquired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results